Whitepaper developed with Pharma Exec magazine on how EIM- Enterprise Information Management- can provide efficiency and kick start innovation by ensuring information flows correctly inside- and outside- the company
Call Girls Thane Just Call 9910780858 Get High Class Call Girls Service
Â
Opentext brings intelligence to Pharma and biotech
1. SPONSORED BY
Bringing Intelligence to Drug
Discovery—The Importance of
Contextual Information at All Levels
An Executive
Summary
Bringing contextual information to multi-step, multi-
department activities involved in commercialization
of new therapeutic agents or devices.
Overview
The biopharmaceutical industry is on the cusp of deploying new comprehensive information
services technologies that can inform key clinical and commercial decisions in ways traditional
information systems cannot. Information management is becoming an essential part of the
intelligent discovery and management processes that span departmental siloes to improve
decision making and reduce costs across the organization. Nearly one-third of delays in deci-
sion making can be traced back to a lack of data integration across departments. Forty percent
of operational costs are lost in information sharing across departments. And, lack of historical
context doubles the cost of early drug discovery.
This article explores the potential for bringing contextual information to the multi-step, multi-
department activities involved in bringing every new therapeutic agent or device to market.
The tools to provide insight across multiple information sources already exist, but few firms
have developed the expertise to apply those tools to bend innovation curves up and cost
curves down.
Achieving True Enterprise-
Wide Intelligence
The biopharmaceutical world is moving toward
an all-digital information world. Impelled by
regulatory, commercial, discovery and devel-
opment demands, most firms have embraced
the need to move away from physical data
repositories to digital information resources
that are available across the organization.
The goal is not just to improve operational
efficiencies, but also to improve insight across
all information sources, departments and
operations to bring intelligence to the entire
organization. The key value is not the depth or
the breadth of information that is available, but
having the right information available to the
right people at the right time to make better
informed, more insightful decisions.
Decision making is a perennial bottle-
neck in any large organization. Biopharma
executives estimate that 30% of the delay
in decision making is due to the simple lack
of data integration (see Figure 1). The right
people do not have the right information at
the right time.
Organizations try to improve decision making
by sharing information across departments.
But without an overarching vision of what
kind of data are available, data sharing is ad
hoc, unpredictable and unsecured. Fully 40%
of operational costs are lost due to a lack of
simple cross-departmental information sharing.
Christopher Wynder, PhD
Content Services Product
Marketing Manager
OpenText
5. Protect your drug discovery pipeline through
understanding past success and failures
Capture
Digitize where
needed
Validate
edge cases
VisualizeProcess,
Classify, Extract
Manage
Central
Information
Repository